Clinical Trial Update: Assessment of the Safety of ABT-308 in Healthy Volunteers and Subjects With Asthma [Phase 1]

View source ↗

Summary

This Phase 1 trial evaluated the safety and tolerability of ABT-308 in healthy volunteers and individuals with asthma; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• ABT-308

Snippet

Sponsor: AbbVie | Conditions: Asthma | Phase 1 | Status: COMPLETED